Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for painless ERCP
ChiCTR2000034711Phase 4Recruiting
- Sponsor
- Xinxiang Central Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and propofol in None (2 arms), sponsored by Xinxiang Central Hospital. Primary endpoints: Heart rate, Systolic blood pressure and 6 more. Started Jul 2020; status: recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2000034711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034711.